Clinical outcome of patients with differentiated thyroid cancer and raised antithyroglobulin antibody levels: a retrospective study

BACKGROUND: Thyroglobulin (Tg) is a specific tumor marker for differentiated thyroid cancer (DTC). However, in the presence of an antithyroglobulin antibody (TgAb), it becomes unreliable. The purpose of the study was to assess the long-term outcome of DTC patients with raised TgAb. METHOD: In a retr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Thyroid Res
Main Authors: Ora, Manish, Nazar, Aftab Hasan, Mishra, Prabhakar, Barai, Sukanta, Arya, Amitabh, Pradhan, Prasanta Kumar, Gambhir, Sanjay
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8048259/
https://ncbi.nlm.nih.gov/pubmed/33858456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13044-021-00099-w
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados